Insulet | PODD - Ebit

Stock Price
224.66
Daily Change
4.82 2.19%
Monthly
-8.80%
Yearly
-14.13%
Q1 Forecast
213.20

Insulet reported $146.3M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
Align Technology USD 224.71M 40.06M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cardinal Health USD 763M 9M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
J&J USD 5.11B 2.3B Dec/2025
Masimo USD 83.9M 200K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Solventum Corp USD 105M 1.58B Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 76.31M Dec/2025
West Pharmaceutical Services USD 162.5M 5.1M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025